DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kazankov K, Barrera F, Møller HJ. , et al.
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
Liver Int 2016;
36 (10) 1549-1557
We do not assume any responsibility for the contents of the web pages of other providers.